ArticleCancer research2022

A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non-Small Cell Lung Cancer.

Jieun Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.